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Summary
The maintenance of mature B cells hinges on signals
emitted from the BAFF-R cell-surface receptor, but
thenatureof thesesignals is incompletelyunderstood.
Inhibition of canonical NF-kB transcription factor ac-
tivity through ablation of the essential scaffold protein
NEMO arrests B cell development at the same stage as
BAFF-Rdeficiency. Correspondingly, activationof this
pathwayby constitutively active IkBKinase2 rendersB
cell survival independent of BAFF-R:BAFF interac-
tions andprevents proapoptotic PKCd nuclear translo-
cation. In addition, canonical NF-kB activity mediates
differentiation and proper localization of follicular
and marginal zone B cells in the absence of BAFF-R,
but not CD19. By replacing BAFF-R signals, constitu-
tive canonical NF-kB signaling, a hallmark of various
B cell lymphomas, causes accumulation of resting B
cells and promotes their proliferation and survival
uponactivation, but doesnot per se induce lymphoma-
genesis. Therefore, canonical NF-kB activity can sub-
stitute for BAFF-R signals in B cell development and
pathogenesis.
Introduction
The survival of mature B cells critically depends on the
presence of two cell-surface proteins: the receptor for
the cytokine B cell activation factor of the TNF family
(BAFF-R, also known as BLyS receptor 3) (Ng et al.,
2005) and the B cell antigen receptor (BCR) (Lam et al.,
1997). Both BAFF-R and BCR keep B cells alive through
signals that either activate prosurvival mechanisms or
inhibit intrinsic apoptosis-inducing programs. In the
case of the BCR, it has been shown that signals trans-
mitted through the associated Iga and Igb transmem-
brane proteins keep B cells alive (Kraus et al., 2004),
but the essential targets of these signals remain unde-
fined. Binding of BAFF to BAFF-R is essential for the
*Correspondence: sasaki@cbr.med.harvard.edu (Y.S.); supprian@
cbr.med.harvard.edu (M.S-S.)
3 Present address: Department of Immunology, National Jewish
Medical and Research Center, UCHSC, 1400 Jackson Street, Den-
ver, Colorado 80206.
4 Additional correspondence information: sasaki@cbr.med.harvard.
edu (Y.S.); rajewsky@cbr.med.harvard.edu (K.R.); supprian@cbr.
med.harvard.edu (M.S.-S.).survival of most mature B cell subpopulations, but not
for B1 cells, which reside in the peritoneal cavity (Ng
et al., 2005). Inhibition of the apoptosis-inducing proper-
ties of protein kinase Cd (PKCd) (Mecklenbrauker et al.,
2004) and activation of NF-kB proteins (Gerondakis
and Strasser, 2003; Siebenlist et al., 2005) have been
proposed as critical downstream mediators.
Mecklenbrauker and coworkers showed that BAFF-
mediated B cell survival involves the control of the sub-
cellular localization of PKCd. In the absence of BAFF,
PKCd can be detected in the nucleus, where it seems
to have a proapoptotic role. Loss of PKCd renders B
cells independent of BAFF-R, consistent with the notion
that BAFF somehow prevents nuclear localization of
PKCd and thereby inhibits its proapoptotic functions
(Mecklenbrauker et al., 2004).
Transcription factors of the NF-kB family play an im-
portant role in B cell maintenance (Gerondakis and
Strasser, 2003; Siebenlist et al., 2005). Two major path-
ways leading to NF-kB activation have been described,
termed the canonical and alternative pathways (Hayden
and Ghosh, 2004). BCR triggering leads to canonical
NF-kB activity, whereas BAFF induces both pathways
(Siebenlist et al., 2005). Specific abrogation of BCR-
induced NF-kB activation by ablation of Bcl-10 (Ruland
et al., 2001) or Caspase recruitment domain family 11
(CARD11, Carma1, Bimp3) (Hara et al., 2003; Jun et al.,
2003) suggested that the survival signal afforded by the
BCR may not depend on NF-kB. The significanceof either
pathway of NF-kB activation in the context of BAFF-R-
mediated B cell survival is not clear. Disruption of alterna-
tive NF-kB signaling severely compromises B cell devel-
opment (Kaisho et al., 2001; Senftleben et al., 2001;
Yamada et al., 2000), and we have previously shown
that in vivo mature B cell maintenance and/or generation
depends on IkB Kinase (IKK)-mediated, canonical NF-kB
signaling (Pasparakis et al., 2002). Combined ablation of
the NF-kB transcription factors p105 (NF-kB1) and p100
(NF-kB2) blocks B cell development at the most imma-
ture stage in the spleen (Claudio et al., 2002). However,
the B cell-autonomous roles of each individual NF-kB
activation pathway remain to be defined.
Five NF-kB proteins have been described in mamma-
lian cells: RelA, c-Rel, RelB, p50, and p52 (Hayden and
Ghosh, 2004). The latter two are generated through pro-
teolytic processing from their respective precursors
p105andp100. Rel transcription factors form various het-
ero- and homodimers, whose transcriptional activities
are limited through binding to members of the inhibitor
of kB (IkB) protein family. The IkB proteins—IkBa, IkBb,
IkB3, and the precursor proteins p105 and p100—share
a domain of five to seven ankyrin repeats, which enables
them to associate with and prevent DNA binding of Rel
dimers. Upon activation, these transcription factors con-
trol the expression of genes involved in inflammation,
protection against apoptosis, and cell cycle progression
(Hayden and Ghosh, 2004; Karin et al., 2002; Siebenlist
et al., 2005). The two NF-kB activation pathways employ
shared and distinct components (Hayden and Ghosh,
2004): for canonical NF-kB activation, the IKK complex,
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730consisting of the two kinases IKK1(IKKa) and IKK2 (IKKb)
and a regulatory subunit, termed NF-kB essential modu-
lator (NEMO or IKKg), phosphorylates IkB proteins at two
conserved N-terminal serine residues, leading to their
polyubiquitylation and destruction by the proteasome.
This pathwayactivates predominantly heterodimers con-
sisting of p50, RelA, and c-Rel. The alternative pathway
involves the proteolytic processing of p100 to p52, initi-
ated by NF-kB-inducing kinase (NIK) and IKK1, indepen-
dently of NEMO, and induces mostly RelB-containing
complexes.
Competition for BAFF limits B cell numbers. In condi-
tions of pathological B cell expansion, as in the case of
lymphomas, this limitation somehow has been over-
come. Elevated BAFF levels were found in serum derived
from patients with non-Hodgkin’s lymphoma (NHL), B
cell chronic lymphocytic leukemia (B-CLL), and multiple
myeloma (MM) (Ng et al., 2005). Certain B lymphoma
cells were shown to express BAFF and one or more of
the BAFF receptors, suggesting the existence of an auto-
crine loop ensuring the survival of these cells (Ng et al.,
2005). In agreement with this notion, BAFF levels in-
crease as tumors of NHL patients transform to a more ag-
gressive phenotype (Novak et al., 2004), and it was
shown that blocking BAFF and a proliferation-inducing
ligand (APRIL) results in apoptosis of NHL B cells (He
et al., 2004) or B-CLL cells (Kern et al., 2004). BAFF-treat-
ment induced NF-kB activation and upregulation of the
NF-kB targets Bcl-2, Bcl-xL, and Mcl-1 in NHL (He
et al., 2004) and B-CLL (Kern et al., 2004) cells, indicating
that BAFF mediates tumor cell survival through NF-kB.
Therefore it appears possible that constitutive activation
of the IKK complex and canonical NF-kB activity, as
found in activated B cell-like diffuse large B cell lym-
phoma (ABC DLBCL), MALT lymphomas, and in Hodgkin
and Reed-Sternberg cells (Karin et al., 2002), serves to
liberate these B cell lymphoma cells from their BAFF
dependence.
To assess the role of NEMO and therefore the ability to
activate the canonical NF-kB pathway throughout B cell
development, we analyzed mice that lack this protein
from the B cell progenitor stage on. NEMO-deficient B
cells, similar to B cells lacking the BAFF-R, develop nor-
mally in the bone marrow but display a severe block in B
cell development at the transitional stages in the spleen.
To evaluate the significance of this finding, we then set
out to determine to what extent canonical NF-kB activity
can replace BAFF-R signaling in B cells. This seemed
particularly interesting in the context of the constitutive
activation of the IKK complex observed in many B cell
tumors. Activation of the canonical NF-kB pathway
through conditional expression of a constitutively active
IKK2 (IKK2ca) specifically in B cells led to hyperplasia,
due to prolonged B cell survival. It also completely un-
coupled B cell development from all aspects of its
BAFF-R dependence. In the absence of BAFF-R, IKK2ca
activity mediated mature B cell survival, possibly through
retaining PKCd in the cytoplasm and the full differentia-
tion of follicular and MZ B cells. This effect is specific
for BAFF-R and NF-kB signaling, since IKK2ca could
not induce differentiation of CD19-deficient MZ B and
B1 cells. IKK2ca-expressing B cells remained in a resting
state, but canonical NF-kB activity strongly enhanced
aIgM-induced proliferation.Results
Ablation of NEMO Blocks B Cell Development at the
Transitional Stages, Similar to Loss of BAFF-R
Our previous analyses demonstrated that IKK2 and
NEMO are required in a B cell-intrinsic fashion for the
maintenance of mature B lymphocytes (Pasparakis
et al., 2002). However, the kinetics and efficiency of
recombination of loxP-flanked alleles achieved by Cre
expressed from the CD19 locus did not allow us to de-
fine the role of canonical NF-kB signaling in early B cell
development in the bone marrow and in transitional B
cells in the spleen (Pasparakis et al., 2002). We therefore
employed the Mb-1Cre strain to ablate NEMO, and
thereby canonical NF-kB activity (Hayden and Ghosh,
2004), in all B lineage cells. Early B cell development
occurred normally in the absence of NEMO (Figure 1A
and data not shown), but there was a dramatic reduction
in peripheral B cell numbers compared to control mice
(Figures 1A–1D). The numbers of mature, AA4.12 B cells
in Mb-1Cre/NemoFL (B cellDNEMO) were reduced to 10%
compared to control mice, and there was a pronounced
block in B cell development at the transitional stage 1
(T1) in the spleen (Figure 1B). The lack of IgD+IgMlow
transitional B cells reflects the T1 to T2 block as defined
by CD23 expression (Figure 1B). In addition, marginal
zone B cells could not be detected in B cellDNEMO mice
by FACS (Figure 1C) or immunohistochemistry (Fig-
ure 1E), and B1 cells were essentially absent from the
peritoneal cavity (Figure 1D) and spleen (data not
shown). The few residual B1 cells found in B cellDNEMO
mice were CD52 B1b cells (data not shown). We per-
formed Southern blot (Figure 2A) and immunoblot
(Figure 2B) analyses on DNA and protein extracts iso-
lated from cells purified by FACS to demonstrate that
the B cells present in B cellDNEMO mice are indeed
deficient for NEMO. The B cell phenotype observed in
B cellDNEMO mice is very similar to that seen in
Tnfrsf13c2/2 (Baff-r2/2) mice (Sasaki et al., 2004;
Shulga-Morskaya et al., 2004), suggesting that BAFF-
R-mediated activation of the canonical branch of
NF-kB activation could play an essential role in B cell
survival. Since the expression of p100 and RelB, both
essential components of the alternative pathway of
NF-kB signaling, is under NF-kB control (Beinke and
Ley, 2004), we evaluated the levels of RelB, p100, and
p52 in purified NEMO-deficient and control B cells by
Western blot (Figure 2B). These analyses revealed that
RelB and p100 are produced in the absence of NEMO,
albeit at lower levels than in control B cells. Significant
amounts of p52 are generated in NEMO-deficient
mature B cells (Figure 2B), indicating that BAFF-R-
dependent p100 processing is still intact. Therefore,
the phenotype of NEMO-deficient B cells should be
mostly due to the absence of canonical NF-kB activity.
BAFF induces phosphorylation of IkBa (Hatada et al.,
2003), but it is not known which of the three BAFF recep-
tors on B cells (BCMA, TACI, or BAFF-R) is responsible
for this effect. Since the BAFF-R is solely responsible
for B cell maintenance (Sasaki et al., 2004; Shulga-Mor-
skaya et al., 2004), BAFF-dependent survival signals
should be transmitted through this receptor. BAFF treat-
ment led to IkBa phosphorylation in control bcl-2tg, but
not in bcl-2tg/BAFF-R-deficient B cells (see Figure S1A
Canonical NF-kB Activity Replaces BAFF-R Signals
731Figure 1. Analysis of Mice Lacking NEMO Specifically in B Cells by Flow Cytometry and Immunohistochemistry
(A–D) FACS analysis of B cell development using the indicated antigens. (A) In the bone marrow, B220lowIgM2 pro- and preB cells develop into
B220lowIgM+ immature B cells. Recirculating B cells are B220highIgM+. (B) B cells enter the spleen as B220+AA4.1+ transitional cells
(B220+AA4.1+IgM+CD232 T1 to B220+AA4.1+IgM+CD23+ T2 cells) and then become B220+AA4.12 mature B cells. Mature B cells can be subdi-
vided into CD1dintCD23high follicular and CD1dhighCD23low MZ B cells in the spleen (C) and into CD19highB220high B 2 and CD19highB220low B 1
cells in the peritoneal cavity (PC) (D). The numbers refer to the percentages of cells in individual gates of total lymphocytes or of the populations
indicated at the side and are representative of eight mice analyzed for each genotype. The B cell numbers shown above the dotplot in (B)
represent mean and standard deviation of four mice in each group.
(E) Staining of spleen sections by immunohistochemistry with anti-B220 (blue) and anti-CD3 (red) reveals B and T cell areas, respectively (upper
panels). Anti-B220 (blue) and anti-MOMA1 (red) shows B cell (blue) follicles surrounded by a ring of metallophilic macrophages (red). Blue stain-
ing outside the follicles represents MZ B cells (lower panels). Magnification is 2003.in the Supplemental Data available with this article on-
line), demonstrating that the BAFF-R is required for
BAFF-induced canonical NF-kB activity, in addition to
the processing of p100 to p52 (Claudio et al., 2002).
BAFF-R-mediated IkBa phosphorylation occurred with
slow kinetics, which paralleled the processing of p100
to p52 (Figure S1A). BAFF stimulation did not reduce
IkBa steady-state protein levels, indicating that induced
degradation of IkBa is balanced by resynthesis, as pro-
posed previously (Hatada et al., 2003). To exclude the
possibility that this finding is due to the transgenic over-
expression of Bcl-2, we repeated the experiment in wild-
type B cells and found phosphorylation of IkBa 24 hr
after BAFF treatment (Figure S1B). Our results show
that BAFF-induced IkBa phosphorylation depends on
the BAFF-R and that disruption of canonical NF-kB
signaling has a similar impact on B cell development
as BAFF-R deficiency.Expression of Constitutively Active IKK2 in B Cells
Selectively Induces Canonical NF-kB Activation
In order to evaluate the extent to which constitutive ca-
nonical NF-kB activation can replace BAFF-R signals,
we decided to activate this pathway in a conditional fash-
ion. We knocked a cDNA encoding IKK2 containing two
serine to glutamate substitutions in the activation loop
of the kinase domain, preceded by a loxP-flanked STOP
cassette, into the ubiquitously expressed ROSA26 locus
(Figure 3A and Figure S2). IKK2 containing these serine to
glutamate mutations (IKK2ca) is constitutively active
(Mercurio et al., 1997). We termed the mutant allele
R26StopFLikk2ca and crossed mice carrying this allele
to theCD19cremouse strain (Rickert et al., 1995) in order
to express IKK2ca exclusively in B cells. B cells from
CD19cre/R26StopFLikk2ca (B cellIkk2ca) (IKK2ca+ B cells)
fluoresce green due to GFP expression from the bicis-
tronic message upon excision of the STOP cassette.
Immunity
732Figure 2. Analysis of NEMO-Deficient B Cells
by Southern Blot and Immunoblot
(A) Southern blot analysis of DNA from FACS-
purified B cells revealing loxP-flanked (FL)
and deleted (Del) Nemo alleles.
(B) Immunoblot analysis of protein extracts
from FACS-purified B cells from B cellDNEMO
and control mice for proteins involved in
canonical and alternative NF-kB signaling.
PLCg2 levels are shown as loading control.
1, B220+IgD2IgM2AA4.1+ pro- and preB
cells; 2, B220+IgD2IgM+AA4.1+ immature B
cells; 3, CD19+B220+AA4.1+ transitional B cells;
4, CD19+B220+AA4.12 mature B cells. Re-
sults shown are representative of three to
four experiments.(Figure 3B), and expression of the Flag-tagged IKK2ca
can be detected by immunoblot (Figure 3C).
These B cells contain very low levels of IkBa and IkBb
(Figure 3D), indicating that IKK2ca is indeed constitu-
tively active. IkB3 levels, on the other hand, are elevated
in IKK2ca+ compared to control B cells (Figure 3D).
Since IkB3 is a transcriptional target of NF-kB (Tian
et al., 2005), it seems that IKK2ca activity induces
more synthesis than degradation of IkB3. IKK2ca+ rest-
ing B cells have higher nuclear levels of p50, RelA, and
c-Rel than control cells, but not of p52 and RelB
(Figure 3E). IKK2ca expression also increases DNA
binding of p50, RelA, and, to a lesser extent, c-Rel, con-
taining nuclear complexes in B cells that were cultured
in medium overnight (Figure 3F). We were not able to de-
tect a clear supershift with antibodies directed against
RelA (Figure 3F), but two different anti-RelA antibodies
also induced the disappearance of the more slowly mi-
grating NF-kB complexes (Figure S3B), indicating that
they are comprised of mostly p50 and RelA. In both con-
trol and IKK2ca+ B cells, p52-containing complexes can
be detected in ex vivo isolated B cells (Figure S3A),
showing that BAFF activates p100 processing in the
presence of IKK2ca in vivo. When cultured in the
absence of BAFF, NF-kB dimers containing p52 largely
disappear (Figure 3F and dat not shown). The conse-
quence of this continuous IKK2 activity is increased
expression of NF-kB targets such as p100, RelB, and
Bcl-xL (Figure 3D). We therefore confirm that in B cells
constitutive activation of IKK2 mediates canonical, but
not alternative, NF-kB activity.
Constitutive Canonical NF-kB Activity Causes B Cell
Hyperplasia, Especially of Marginal Zone B Cells
The CD19cre allele does not facilitate efficient expres-
sion of IKK2ca during bone marrow B cell development
in B cellIkk2ca mice, and the constitutive activation of
IKK2 present in B lineage cells has no obvious effect on
early B cell development (Figures S4A and S4B). Virtually
all B cells express IKK2ca from the transitional stages
onward in the spleens of B cellIkk2ca mice (Figure S4C),
resulting in an increase in peripheral B cell numbers
(Figures 4A and 4B), which is due to an overall increase
in mature AA4.12B cells (130.26 32.73 106 in B cellIkk2caversus 56.4 6 9.3 3 106 in control mice; n = 7–8)
(Figure 4A). IKK2ca+ B cells contain a significantly ex-
panded population of marginal zone (MZ) B cells, as
shown by FACS (22.36 6.93 106 in B cellIkk2ca versus 46
1.53 106 in control mice; n = 7–8) (Figure 4A) and immu-
nohistochemistry (Figure 4B), underscoring the impor-
tance of canonical NF-kB signaling in the generation of
this subset. IKK2ca+ B cells show elevated levels of
CD23, consistent with the presence of two kB sites in
the promoter of the CD23 gene (Tinnell et al., 1998). How-
ever, the presence of CD23low transitional T1 (data not
shown) and MZ (Fig. 4A) B cells shows that in IKK2ca+
B cells CD23 expression is still developmentally regu-
lated. To evaluate whether the elevated B cell numbers
are due to increased generation, longevity, or prolifera-
tive activity of B cells, we performed BrdU pulse-chase
experiments. After 14 days of receiving BrdU in the drink-
ing water, splenic IKK2ca+ B cells contained less BrdU+
cells than control B cells (Figure 4C), demonstrating
that constitutive IKK2 activity does not lead to acceler-
ated B cell development or enhanced proliferation. We
confirmed the absence of proliferating cells in IKK2ca+
and control splenic B cells by analysis of DNA content
(Figure 7A and data not shown), demonstrating that the
BrdU+ B cells detected during the pulse period are in-
deed newly generated cells from the bone marrow. Dur-
ing the 70 day chase period, BrdU+ B cells are lost
through either death or cellular division. Since nearly all
IKK2ca+ and control splenic B cells are in a resting state,
the fact that the percentage of BrdU+ cells of splenic B
cells dropped faster in control than in IKK2ca+ B cells
(Figure 4C) indicates that IKK2ca+ B cells have on aver-
age a longer life span than wild-type B cells. Since we
did not differentiate between individual B cell subsets,
it is possible that phenomena such as the preferential re-
cruitment of IKK2ca-expressing B cells into the MZ B cell
compartment contribute to the reduced B cell turnover.
However, given the absence of increased B cell genera-
tion and IKK2ca-induced proliferation, it is clear from the
data that the doubling of B cell numbers, effected by
IKK2ca, cannot be explained by changes in the size of in-
dividual B cell subsets. Therefore, IKK2ca causes B cell
hyperplasia not through increasing their generation or in-
ducing proliferation but by enhancing B cell life span.
Canonical NF-kB Activity Replaces BAFF-R Signals
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tivity through IKK2ca Expression
(A) Scheme of the R26-StopFLIkk2ca trans-
gene. IKK2ca is expressed under control of
the endogenous ROSA26 promoter after
Cre-mediated deletion of the STOP cassette.
(B) B cell-specific expression of the IRES-
eGFP can be verified by FACS analysis.
(C) a-Flag immunoblot analysis detecting the
flag-tagged IKK2ca protein in B cells from
control (1) and B cellIkk2ca (2) mice. Akt-levels
are shown as loading control.
(D) Immunoblot analysis of steady-state
levels of proteins that are involved in NF-kB
signaling. b-actin levels are shown as loading
control.
(E) Cytoplasmic (Cyt) and nuclear (Nuc) levels
of Rel proteins were analyzed by immunoblot.
Purity of cytoplasmic and nuclear extract
preparations were verified by a-tubulin blot
and equal loading by blotting for b-actin.
(F) DNA-binding analysis of NF-kB subunits by
EMSA supershift. Nuclear extracts were pre-
pared from purified splenic B cells and super-
shifted with the indicated antibodies. Results
are representativeof three tofiveexperiments.Constitutive IKK2 Activity Can Substitute
for All Known Functions of BAFF-R in Mature
Resting B Cells
To test whether the signal elicited by IKK2ca can substi-
tute for BAFF-R signaling, we cultured IKK2ca+ and
control B cells with or without BAFF. Whereas BAFF
treatment increased the numbers of surviving control B
cells, IKK2ca+ B cells survived equally well in culture as
control B cells with BAFF, and addition of BAFF only
slightly enhanced survival (Figure 4D). In order to verify
this finding in vivo, we generated B cellIkk2ca-BAFF-R-de-
ficient mice. The BAFF-R is essential for the survival of
follicular B cells, generation of MZ B cells, and mainte-
nance of adequate expression levels of CD21 and CD23
in B cells. Expression of IKK2ca in B cells lacking BAFF-
R led to relief of the developmental block at the T1 to T2
transition of B cell development as judged by IgM/
CD23- (Figure 5A) and IgM/IgD-expression (data not
shown). This leads to the generation of normal numbers
of AA4.12 mature B cells, including CD21+CD23+ follicu-
lar and CD21highCD23lowCD1dhigh MZ B cells (Figure 5A).
Immunohistochemistry revealed that spleens from B
cellIkk2ca-BAFF-R-deficientmice contain a well-organized
lymphoid microarchitecture, displaying clear B and T cell
areas and normal follicles with a distinct marginal zone
area (Figure 5B).
Canonical NF-kB Activity Prevents Proapoptotic
Nuclear Entry of PKCd in Response to BAFF
Deprivation
B cell apoptosis resulting from withdrawal of BAFF has
been linked to nuclear localization of PKCd. We show
here that the nuclear accumulation of PKCd is down-
stream of IKK2 activation, since PKCd does not translo-
cate to the nucleus of IKK2ca+ B cells cultured in the
absence of BAFF or lacking the BAFF-R (Figure 5C).
Expression of IKK2ca did not restore processing of
p100 to p52 in BAFF-R-deficient B cells (Figure 5C), dem-
onstrating that in the presence of canonical NF-kB activityp100 processing is not required for B cell development.
Enforced expression of Bcl2 also inhibits PKCd nuclear
translocation (Figure 5D) and permits the development
of large numbers of BAFF-R-deficient AA4.12 B cells
(Sasaki et al., 2004). We therefore suggest that NF-kB sig-
naling controls the proapoptotic functions of PKCd
through the induction of NF-kB-dependent Bcl-2 family
proteins.
IKK2 Activity Cannot Replace CD19-Dependent
Differentiation Signals
Loss of CD19 results in various B cell deficiencies, includ-
ing reduced numbers of follicular B cells and absence of
MZ B and B1 cells (Engel et al., 1995; Rickert et al., 1995).
Ablation of phosphatase and tensin homolog (PTEN),
a functional antagonist of PI3K, led to MZ and B1 cell
development in CD192/2 mice (Anzelon et al., 2003),
demonstrating that phosphoinositide 3-kinase (PI3K)
activity can induce differentiation of these B cell subsets
in the absence of CD19. Activation of PI3K also leads to
NF-kB activation (Donahue and Fruman, 2004). There-
fore, we evaluated to what extent expression of IKK2ca
can compensate for the lack of CD19. We found that
IKK2ca increased the numbers of mature AA4.12 B cells
in B cellIkk2ca-CD192/2 mice (Figure 6A), but did not in-
duce MZ B or B1 cell development (Figures 6A–6C).
This result shows that IKK2ca-mediated activation of
canonical NF-kB is not sufficient to replacedifferentiation
signals downstream of CD19-dependent PI3 kinase
activation.
IKK2ca Expression Keeps B Cells in a Resting State,
but Promotes Proliferation upon Activation
We performed cell cycle analyses on purified IKK2ca+
and control B cells to directly test the role of constant
canonical NF-kB activation on B cell division. Nearly all
ex vivo isolated IKK2ca+ B cells were in a resting state,
similar to control B cells (Figure 7A). However, 1 or 2
days after BCR crosslinking, IKK2ca+ B cells contained
Immunity
734Figure 4. B Cell Development in B CellIkk2ca Mice
(A) FACS analysis of cells stained for the indicated antigens shows the proportions of B220+AA4.12mature and CD1dhighCD23low MZ B cells in B
cellIkk2ca compared to control mice. The bold numbers indicate total B cell numbers (mean and standard deviation 3 106 of six mice for each
group), and numbers next to individual gates refer to the percentages of cells in individual gates of total lymphocytes (first row) and of CD19+
B cells (second row).
(B) Staining of spleen sections by immunohistochemistry with anti-CD19 (blue) and anti-MOMA1 (red) shows the ring of metallophilic macro-
phages (red) encircling the B cell (blue) follicles. Blue staining outside the follicles represents MZ B cells (upper panels). Anti-CD19 (blue) and
anti-CD3 (red) staining reveals B and T cell areas, respectively (lower panels). Magnification is 2003.
(C) BrdU pulse-chase experiment: mice were fed BrdU for 2 weeks, and the fraction of splenic BrdU+ B cells was determined at days 7 and 14 (pulse)
and at days 42 and 70 (chase). Three mice of each genotype (black circles, controls; green triangles, B cellIkk2ca) were analyzed per time point.
(D) Splenic B cells of the indicated genotypes (black, control; green, B cellIkk2ca) were cultured in medium with (triangles) or without (circles) BAFF.
The number of live cells is shown as percentage of initial input. Data represent the means and standard errors of five independent experiments.more cells in S phase and less apoptotic cells than
control B cells, indicating that canonical NF-kB activity
enhances aIgM-induced proliferation in addition to
protecting against apoptosis (Figure 7A). Similarly,
CMTMR-labeled IKK2ca+ B cells started dividing earlier,
underwent more cell divisions, and stayed alive longer
than control B cells in response to stimulation with
aIgM (Figure 7B). As a result, 4 days after start of cul-
tures with 2 3 106 B cells in the presence of aIgM, 3 3
106 live IKK2ca+ B cells could be recovered, in compar-
ison to 0.123 106 live control B cells. Biochemical anal-
ysis of NF-kB-dependent proteins involved in cell cycle
regulation (Karin et al., 2002; Rosenwald and Staudt,
2003) revealed no significant differences between rest-
ing IKK2ca+ and control B cells (Figure 7C). Proviral
integration site (Pim)-1 and IRF-4 were included in this
analysis because they belong to a group of NF-kB-
dependent genes that are highly expressed in ABC
DLBCL and which also include Bcl-2, FLICE-like inhibi-
tory protein (FLIP), and cyclin D2. After stimulation
with aIgM, IKK2ca+ B cells contained higher levels of cy-
clin D3, cyclin E, Cdk4, Cdk6, and especially of pim-1(Figure 7C). These findings demonstrate that IKK2 activ-
ity alone does not induce cell cycle entry but dramati-
cally promotes the proliferation of activated B cells.
Discussion
Canonical NF-kB activity is essential for B cell mainte-
nance. Signals from two receptors, BCR and BAFF-R,
are essential for the survival of mature, resting B cells,
and both activate the canonical NF-kB pathway. Loss
of Bcl-10 essentially prevents the generation of B1 cells
but affects the numbers of other mature peripheral B cells
(B2) only modestly (Xue et al., 2003). Therefore, it appears
unlikely that NF-kB/Rel proteins play a major role in BCR-
mediated maintenance signals in B2 cells. Since B cell-
specific ablation of NEMO, and therefore canonical NF-
kB activity, completely interferes with the generation of
B1 cells, we present here further evidence that this partic-
ular B cell subset depends on BCR-mediated activation
of the canonical NF-kB pathway. In B2 cells, on the other
hand, it seems possible that the BAFF-R signals B cell
survival via NF-kB (Gerondakis and Strasser, 2003;
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(A) FACS analysis shows the proportions of individual B cells populations in the spleens of mice of the indicated genotypes: B220+AA4.1+ im-
mature B cells (T1, B220+AA4.1+IgM+CD232; T2, B220+AA4.1+IgM+CD23+) and B220+AA4.12 mature B cells (CD1dlowCD21intCD23high follicular
and CD1dhighCD21highCD23low MZ B cells). The numbers refer to the percentages of cells in individual gates of total lymphocytes (first row), of
CD19+AA4.1+ or eGFP+AA4.1+ transitional (second row), and of CD19+ B cells (third and last row). The total splenocyte numbers were 1396 203
106 in Tnfrsf13c2/2 (Baff-r+/2) and 140 6 14 3 106 in Tnfrsf13c2/2-B cellIkk2ca mice (n = 4).
(B) The organization of splenic B cell follicles was visualized by immunohistochemistry. Anti-B220 (blue) stains follicular B cells inside the ring of
MOMA1+ (red) metallophilic macrophages and MZ B cells outside of it (upper panels). Anti-B220 (blue) and anti-CD3 (red) staining reveals B and
T cell areas, respectively (lower panels). Magnification is 2003.
(C and D) Cytoplasmic (Cyt) and nuclear (Nuc) levels of PKCd, p100/p52, and RelB were analyzed by immunoblot in extracts prepared from B cells
cultured in medium with or without 500 ng BAFF/ml for 24 hrs. Results are representative of three independent experiments. (C) B cells were
purified from control, B cellIkk2ca, and Tnfrsf13c2/2-B cellIkk2ca mice and from (D) Tnfrsf13c2/2-Bcl-2tg mice. Tubulin and Lamin B levels demon-
strate purity of cytosolic and nuclear fractions, respectively. b-actin levels are shown to demonstrate equal loading.Siebenlist et al., 2005). However, BAFF-R ligation stimu-
lates both the canonical and the alternative pathway of
NF-kB activation, and it is thought that it preferentially
stimulates the latter (Morrison et al., 2005). Alternative
NF-kB activity contributes to BAFF-R-mediated survival,
but the BAFF-R must provide additional survival signals,
since loss of the ability to induce alternative signaling
leads to a milder reduction in B cell numbers than lack
of BAFF or BAFF-R (Siebenlist et al., 2005). The increase
in phosphorylated IkBa, mediated by BAFF, which we
show to depend on the BAFF-R, follows a slow kinetic,
consistent with the notion of a continuous, low-level
maintenance signal. The fact that BAFF treatmentinduces IkBa phosphorylation and p100 processing
with a similar kinetics supports the notion that a common
upstream protein, most likely NIK (Ramakrishnan et al.,
2004), activates both canonical and alternative NF-kB in
response to BAFF. However, it is also possible that
BAFF activates canonical NF-kB through indirect mecha-
nisms. Our finding that ablation of NEMO produces
a block in B cell development similar to loss of the
BAFF-R supports the idea that canonical NF-kB signals
play a role in BAFF-mediated B cell survival and/or differ-
entiation. Loss of NEMO, although reflecting impaired
signaling to canonical NF-kB activation in response to
triggering of the BCR and perhaps other not yet identified
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milder B cell phenotype than lack of BAFF-R (Sasaki
et al., 2004; Shulga-Morskaya et al., 2004). Therefore,
other BAFF-R-induced signaling pathways, such as the
alternative NF-kB pathway and the regulation of Bim by
ERK (Craxtonet al., 2005), could contribute to B cell main-
tenance. We did not detect any obvious differences in
bone marrow development between NEMO-deficient
and control B cells, in agreement with the in vitro data
of Kimet al. (2003) and arecurrently investigating whether
specific processes linked to NF-kB transcription factors,
such as receptor editing (Verkoczy et al., 2005), depend
on NEMO.
Overexpression of Bcl2 (Rahman and Manser, 2004;
Sasaki et al., 2004; Tardivel et al., 2004) or Bcl-xL
(Amanna et al., 2003) leads to the development of large
Figure 6. Effects of IKK2ca Expression on CD19-Deficient B Cells
Results are representative of two independent experiments.
(A) FACS analysis of cells stained for the indicated antigens shows
the proportions of B220+AA4.1+immature and B220+AA4.12mature
B cells (upper panels). MZ B cell generation was visualized through
staining for CD23/CD1d (lower panels). The numbers refer to the
percentages of cells in individual gates of total lymphocytes (upper
panels) and of CD19+B cells (middle and lower panels).
(B) Immunohistochemistry shows B cell follicles in the spleens of
control, CD192/2and B cellIkk2ca-CD192/2mice. Anti-B220 (blue)
stains follicular B cells inside the ring of MOMA1+(red) metallophilic
macrophages and MZ B cells outside of it. Magnification is 2003.
(C) FACS analysis of cells stained for the indicated antigens reveals
IgM+CD43+B1 and IgM+CD432B2 cells in the peritoneal cavities of
control, CD192/2and B cellIkk2ca-CD192/2mice.numbers of BAFF-R-deficient B cells. However, only fol-
licular B cells, with a surface phenotype reminiscent of
immature cells and lacking proper follicular organization,
are generated in these mice. In contrast, IKK2 activity,
and therefore canonical NF-kB signaling, can fully com-
pensate for BAFF-R in the generation and maintenance
of mature B cell subsets, namely survival and differentia-
tion of properly organized mature follicular and MZ B
cells, as well as the expression of CD21 and CD23. This
finding excludes the possibility that BAFF-expressing
stromal cells (Gorelik et al., 2003) directly act as an orga-
nizing principle ensuring the proper follicular location of
B cells.
Our data indicate that BAFF-R-mediated cytoplasmic
retention of PKCd, which prevents its nuclear proapop-
totic activities, is downstream of canonical NF-kB activ-
ity and Bcl-2 expression. Therefore, nuclear exclusion of
PKCd through NF-kB-induced expression of antiapop-
totic members of the Bcl-2 family could contribute to
BAFF-R-dependent B cell maintenance. The NF-kB-
dependent, BAFF-R-induced mechanisms mediating
differentiation of follicular and MZ B cells are currently
under investigation.
The fact that canonical NF-kB signaling can increase
the numbers of follicular B cells generated in the ab-
sence of CD19 is consistent with the increase in follicular
B cell numbers in cd192/2 mice through enforced ex-
pression of Bcl-2 (Otero et al., 2003) and the rescue of
B cell deficiency in p85a2/2 mice, which lack the major
regulatory subunit of PI3K, by transgenic expression of
Bcl-xL, another NF-kB target (Suzuki et al., 2003). On
the other hand, IKK2ca expression does not lead to
the generation of CD19-deficient MZ B or B1 cells, dem-
onstrating that the CD19-induced PI3K activity does not
signal MZ B and B1 cell differentiation via canonical
NF-kB activity. This conclusion is potentially in conflict
with data from Otero et al., who reported that transgenic
expression of Bcl-2 can rescue the generation of CD19-
deficient MZ B cells, but not B1 cells (Otero et al., 2003).
Here, we provide evidence for an important role of ca-
nonical NF-kB signaling in BAFF-R-mediated B cell sur-
vival and differentiation, through in vivo ablation and con-
stitutive induction of this particular pathway. Although
constitutive canonical NF-kB activation can replace
BAFF-R signals and inhibition of this pathway mimics
loss of BAFF-R to a large extent, we cannot precisely de-
fine the respective impact of thecanonical and alternative
NF-kB pathway on BAFF-R signaling during normal B cell
physiology. Specific mutations in the BAFF-R or down-
stream mediators disabling selectively either of the two
pathways and/or a comparison of the B cell-specific inhi-
bition of each of the two branches of NF-kB activation will
be required to fully address this question. To this end we
are currently generating mouse models to ablate and
constitutively activate alternative NF-kB signaling.
Our knockin system to conditionally activate canoni-
cal NF-kB through expression of constitutively active
IKK2 is uniquely suited to explore the role of this signal-
ing pathway in the pathogenesis of B cell malignancies,
where canonical NF-kB signaling is constitutively active.
An important result of the present experiments is the
demonstration that despite its involvement in the control
of both cell survival and proliferation, constitutive ca-
nonical NF-kB signaling leads to B cell hyperplasia and
Canonical NF-kB Activity Replaces BAFF-R Signals
737Figure 7. Effects of IKK2 Activity on the Sur-
vival and Proliferation of Activated B Cells
(A) FACS analysis of DNA content in resting,
freshly isolated (day 0), or aIgM-stimulated
IKK2ca+ and control B cells after 1 or 2
days. The percentage of cells in the different
phases of the cell cycle (G0/G1, S, G2/M)
and of dead cells (Apo) is given in each quad-
rant.
(B) Histograms displaying CMTMR dilution of
IKK2ca+ (open) and control B cells (filled grey)
after 3 days in medium without stimulation
(upper panel) or 2–4 days after aIgM stimula-
tion. Numbers (black, IKK2ca+; grey, control)
indicate percentage of live B cells in the
respective cultures. Representative of four
independent experiments.
(C) Immunoblot analysis of proteins involved
in proliferation. b-actin levels are shown to
demonstrate equal loading. Extracts were
purified from IKK2ca+ and control B cells at
the indicated days after stimulation with
aIgM.BAFF independence, without by itself inducing B cell
proliferation. This is underscored by our finding that in-
creased canonical NF-kB activity, mediated by expres-
sion of IKK2ca from two alleles, while further elevating
B cell numbers, still maintains the resting state of the
cells (data not shown). However, once cell division is
initiated by some mitogenic stimulus, IKK2ca+ B cells
divide much more rapidly than control B cells.
Therefore, we propose that constitutive activation of
the classical pathway of NF-kB, be it through chronic
infections or chromosomal translocations as in MALT
lymphomas or genetic mutations or viral infections as in
certain cases of Hodgkin’s lymphoma (Karin et al.,
2002), while not being oncogenic by itself, predisposes
B cells to transformation in at least two ways: it releases
the B cells from their dependence of extracellular survival
signals, such as BAFF, and when an additionaloncogenic
event induces the cells to divide, it protects them against
activation-induced apoptosis and strongly enhances
proliferation.
With respect to normal B cell physiology, our results
demonstrate that BAFF-R ligation induces canonical
NF-kB activity and that expression of IKK2ca renders ma-
ture resting B cells fully independent of BAFF. NF-kB
can mediate BAFF-dependent B cell survival through
upregulation of antiapoptotic proteins of the Bcl-2 familyand suppression of PKCd nuclear translocation and has
additional roles in BAFF-dependent differentiation of
marginal zone B cells. Together with the phenotypic
similarities between BAFF-R- and NEMO-deficient B
cells, our data provide strong evidence for a role of




To generate tissue-specific IKK2ca-transgenic mice, we cloned
a loxP-flanked neor-stop cassette into a modified version of
pROSA26-1 (Zambrowicz et al., 1997). We then added a cDNA en-
coding a flag-tagged constitutively active form of murine IKK2
(IKK2ca), a frt-flanked IRES-eGFP cassette, and a bovine polyade-
nylation sequence (R26StopFLIkk2ca; Figure S2). Bruce-4 ES cells
were transfected, cultured, and selected as previously described
(Schmidt-Supprian et al., 2000). Mice carrying conditional Nemo
alleles were described previously (Schmidt-Supprian et al., 2000).
Mb-1Cre mice were generated through knockin of a Cre-encoding
cDNA into the mb-1 locus and will be described elsewhere (E.H.,
unpublished data). Except for the Mb-1Cre mice, which were
BALB/c:C57BL/6 mixed, all mice were of a pure C57BL/6 genetic
background and were bred and maintained in specific pathogen-
free conditions; all mouse protocols were approved by the Harvard
University Institutional Animal Care and Use Committee and by the
CBR Institute for Biomedical Research.
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738Flow Cytometry and Cell Purifications
Single-cell suspensions prepared from various lymphoid organs
were stained with the following monoclonal antibodies conjugated
to phycoerythrin (PE), Peridin-Chlorophyll (PerCP), allophycocyanin
(APC), or biotin: anti-CD19 (ID3), anti-CD21 (7G6), anti-CD23 (B3B4),
anti-CD1d (1B1) (all from BD Pharmingen), and anti-AA4.1 (eBio-
science). For in vitro proliferation studies, B cells were labeled
with 10 mM Celltracker Orange (Invitrogen) for 15 min at 37ºC. All
samples were acquired on a FACSCalibur (BD Pharmingen), and
results were analyzed with Flow-Jo and CellQuest software. B cells
were purified by MACS (Miltenyi) and by cell sorting using a FACS
DiVA (Becton Dickinson). MACS-purified populations were >85%
pure and FACS purifications yielded >95% purity.
Immunohistochemistry
For staining of B cells and macrophages, frozen 6 mm sections were
thawed, air-dried, fixed in acetone, and stained for 1 hr at RT in
a humidified chamber with biotinylated rat anti-CD19 (BD Pharmin-
gen) or rat anti-B220 and rat anti-MOMA-1 (CEDARLANE) followed
by HRP-conjugated goat anti-rat IgG and alkaline phosphatase-
conjugated streptavidin. For staining of B and T cells, sections
were stained for 1 hr at RT in a humidified chamber with biotinylated
anti-CD19 and armenian hamster anti-CD33 (eBioscience).
BrdU Pulse-Chase Experiments
Mice were fed with drinking water containing 0.8 mg/ml BrdU (Sigma)
for 14 days. At different times during and after the BrdU pulse, spleno-
cytes were purified and stained using the APC BrdU Flow kit (BD
bioscience).
Cell Cycle Analysis
Purified B cells (2 3 107) were cultured in 5 ml medium and stimu-
lated with 10 mg/ml of aIgM. At each time point, 2 3 106 cells were
harvested and washed with PBS. Cells were resuspended in 500 ml
PBS and fixed by adding 1 ml of ice-cold 95% ethanol. After over-
night incubation on ice, the cells were washed with PBS and resus-
pended in 200 ml of 0.5 mg/ml RNaseA and incubated at 37ºC for 20
min. Subsequently, 200 ml of 40 mg/ml propidium iodide (Sigma) was
added, and the B cells were incubated for 30 min at RT. DNA content
was then quantified by FACS.
Immunoblot Analysis and Electrophoretic Mobility Shift Assay
To prepare whole-cell lysates, B cells were lysed for 10 min on ice by
RIPA buffer + 1% aprotinin and 2 mM PMSF, followed by 10 min cen-
trifugation. For preparation of cytoplasmic fractions, cells were
washed once with PBS and resuspended in 100 ml buffer A (10 mM
HEPES [pH7.8], 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, 5 mg/ml apro-
tinin, 2 mM pepstatin, 10 mg/ml leupeptin, 1 mM PMSF, 5 mM NaF, 1
mM Na3VO4, and 0.5% Triton X-100), followed by 10 min centrifuga-
tion. For nuclear extracts, the nuclei were then resuspended in buffer
C (50 mM HEPES [pH 7.8], 420 mM KCl, 0.1 mM EDTA, 5 mM MgCl2,
10% glycerol, 1 mM DTT, 5 mg/ml aprotinin, 2 mM pepstatin, 10 mg/ml
leupeptin, 1 mM PMSF, 5 mM NaF, 1 mM Na3VO4) for EMSA or resus-
pended in RIPA buffer + 1 mM DTT, 5 mg/ml aprotinin, 2 mM pepstatin,
10 mg/ml leupeptin, 1 mM PMSF, 5 mM NaF, 1 mM Na3VO4, and then
sonicated three times for 5 min for immunoblot for PKCd. PVDF mem-
branes were blotted with the indicated antibodies. EMSA was
performed essentially as described (Schmidt-Supprian et al., 2000).
For supershift assays, nuclear extracts or whole-cell lysates were
preincubated for 30 min at RT with the indicated antibodies.
Cell Survival Assay
Splenic B cells were purified by depletion of CD43+ cells by MACS
(Miltenyi). B cells (43 106) were cultured in 1 ml medium with or with-
out 500 ng/ml human BAFF (Pelletier et al., 2003). At each time point,
live cells were counted.
Supplemental Data
The Supplemental Data for this article, which includes Supplemental
Figures, can be found online at http://www.immunity.com/cgi/
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